PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

• 收藏
• 分享

专利权人:

Vesna Kroselj

发明人:

Vesna Kroselj

申请号：

US13807882

公开号：

US20130177652A1

申请日:

2011.07.01

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The invention relates to pharmaceutical oral dosage forms of the active substance ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate (dabigatran etexilate) and the pharmacologically acceptable salts thereof, in particular dabigatran etexilate methanesulfonate.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/